Epidyolex treats two rare types of epilepsy, and Sativex spray is for MS sufferers

Two cannabis-based medicines have been recommended for use on the NHS for the first time.

Epidyolex has been approved for two rare types of epilepsy, Lennox-Gastaut and Dravet syndromes, and Sativex spray has been recommended for muscle spasms associated with multiple sclerosis (MS).

Continue reading...